Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD

Csaba Kovesdy, John E. Anderson, Kamyar Kalantar-Zadeh

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Background. Metabolic acidosis, usually manifested by low serum bicarbonate level, is common in chronic kidney disease (CKD) and appears to be associated with higher mortality in dialysis patients. It is not known whether a similar association is present in patients with non-dialysisdependent CKD (NDD-CKD). Methods. We used multivariable-adjusted Cox models to examine the association between baseline and time-variable serum bicarbonate (measured as total CO2) with the outcomes of all-cause mortality and the composite of predialysis mortality or end-stage renal disease in 1240 male patients with moderate and advanced NDD-CKD. Results. Serum bicarbonate showed a significant U-shaped association with all-cause mortality, with the highest mortality rate observed in patients with baseline serum bicarbonate levels <22 mmol/L [multivariable-adjusted hazard ratio (95% confidence interval) for patients with serum bicarbonate <22 mmol/L versus ≥22 mmol/L: 1.33 (1.05 1.69), P = 0.02] and the lowest mortality observed in patients with baseline serum bicarbonate of 2629 mmol/L. The associations between lower serum bicarbonate level and mortality were more accentuated in subgroups of patients with better nutritional status and lower inflammation. Conclusions. Both lower and higher serum bicarbonates are associated with increased all-cause mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if therapeutic interventions aimed at optimizing serum bicarbonate can result in improved outcomes in this population.

Original languageEnglish (US)
Pages (from-to)1232-1237
Number of pages6
JournalNephrology Dialysis Transplantation
Volume24
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Bicarbonates
Chronic Renal Insufficiency
Mortality
Serum
Acidosis
Nutritional Status
Proportional Hazards Models
Chronic Kidney Failure
Dialysis
Clinical Trials
Confidence Intervals
Inflammation

All Science Journal Classification (ASJC) codes

  • Nephrology
  • Transplantation

Cite this

Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD. / Kovesdy, Csaba; Anderson, John E.; Kalantar-Zadeh, Kamyar.

In: Nephrology Dialysis Transplantation, Vol. 24, No. 4, 01.04.2009, p. 1232-1237.

Research output: Contribution to journalArticle

@article{08c6df311fa34cc28b9fc574b9da516b,
title = "Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD",
abstract = "Background. Metabolic acidosis, usually manifested by low serum bicarbonate level, is common in chronic kidney disease (CKD) and appears to be associated with higher mortality in dialysis patients. It is not known whether a similar association is present in patients with non-dialysisdependent CKD (NDD-CKD). Methods. We used multivariable-adjusted Cox models to examine the association between baseline and time-variable serum bicarbonate (measured as total CO2) with the outcomes of all-cause mortality and the composite of predialysis mortality or end-stage renal disease in 1240 male patients with moderate and advanced NDD-CKD. Results. Serum bicarbonate showed a significant U-shaped association with all-cause mortality, with the highest mortality rate observed in patients with baseline serum bicarbonate levels <22 mmol/L [multivariable-adjusted hazard ratio (95{\%} confidence interval) for patients with serum bicarbonate <22 mmol/L versus ≥22 mmol/L: 1.33 (1.05 1.69), P = 0.02] and the lowest mortality observed in patients with baseline serum bicarbonate of 2629 mmol/L. The associations between lower serum bicarbonate level and mortality were more accentuated in subgroups of patients with better nutritional status and lower inflammation. Conclusions. Both lower and higher serum bicarbonates are associated with increased all-cause mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if therapeutic interventions aimed at optimizing serum bicarbonate can result in improved outcomes in this population.",
author = "Csaba Kovesdy and Anderson, {John E.} and Kamyar Kalantar-Zadeh",
year = "2009",
month = "4",
day = "1",
doi = "10.1093/ndt/gfn633",
language = "English (US)",
volume = "24",
pages = "1232--1237",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD

AU - Kovesdy, Csaba

AU - Anderson, John E.

AU - Kalantar-Zadeh, Kamyar

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Background. Metabolic acidosis, usually manifested by low serum bicarbonate level, is common in chronic kidney disease (CKD) and appears to be associated with higher mortality in dialysis patients. It is not known whether a similar association is present in patients with non-dialysisdependent CKD (NDD-CKD). Methods. We used multivariable-adjusted Cox models to examine the association between baseline and time-variable serum bicarbonate (measured as total CO2) with the outcomes of all-cause mortality and the composite of predialysis mortality or end-stage renal disease in 1240 male patients with moderate and advanced NDD-CKD. Results. Serum bicarbonate showed a significant U-shaped association with all-cause mortality, with the highest mortality rate observed in patients with baseline serum bicarbonate levels <22 mmol/L [multivariable-adjusted hazard ratio (95% confidence interval) for patients with serum bicarbonate <22 mmol/L versus ≥22 mmol/L: 1.33 (1.05 1.69), P = 0.02] and the lowest mortality observed in patients with baseline serum bicarbonate of 2629 mmol/L. The associations between lower serum bicarbonate level and mortality were more accentuated in subgroups of patients with better nutritional status and lower inflammation. Conclusions. Both lower and higher serum bicarbonates are associated with increased all-cause mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if therapeutic interventions aimed at optimizing serum bicarbonate can result in improved outcomes in this population.

AB - Background. Metabolic acidosis, usually manifested by low serum bicarbonate level, is common in chronic kidney disease (CKD) and appears to be associated with higher mortality in dialysis patients. It is not known whether a similar association is present in patients with non-dialysisdependent CKD (NDD-CKD). Methods. We used multivariable-adjusted Cox models to examine the association between baseline and time-variable serum bicarbonate (measured as total CO2) with the outcomes of all-cause mortality and the composite of predialysis mortality or end-stage renal disease in 1240 male patients with moderate and advanced NDD-CKD. Results. Serum bicarbonate showed a significant U-shaped association with all-cause mortality, with the highest mortality rate observed in patients with baseline serum bicarbonate levels <22 mmol/L [multivariable-adjusted hazard ratio (95% confidence interval) for patients with serum bicarbonate <22 mmol/L versus ≥22 mmol/L: 1.33 (1.05 1.69), P = 0.02] and the lowest mortality observed in patients with baseline serum bicarbonate of 2629 mmol/L. The associations between lower serum bicarbonate level and mortality were more accentuated in subgroups of patients with better nutritional status and lower inflammation. Conclusions. Both lower and higher serum bicarbonates are associated with increased all-cause mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if therapeutic interventions aimed at optimizing serum bicarbonate can result in improved outcomes in this population.

UR - http://www.scopus.com/inward/record.url?scp=65349120865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349120865&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfn633

DO - 10.1093/ndt/gfn633

M3 - Article

C2 - 19015169

AN - SCOPUS:65349120865

VL - 24

SP - 1232

EP - 1237

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 4

ER -